February 15, 2019
RegMed Investors’ (RMi) closing bell: a rebound of the oversold
February 14, 2019
RegMed Investors’ (RMi) closing bell: buzz kill
February 13, 2019
RegMed Investors’ (RMi) closing bell: resistance
February 12, 2019
RegMed Investors’ (RMi) closing bell: tailwinds keep the sector up
February 11, 2019
RegMed Investors’ (RMi) closing bell: investing in the sector is an opportunity and a risk
February 8, 2019
RegMed Investors’ (RMi) closing bell: volume stays down
February 7, 2019
RegMed Investors’ (RMi) closing bell: blood drips from the cracks in the sector
February 6, 2019
RegMed Investors’ (RMi) closing bell: the downside landing has more to being overbought or even oversold – sentiment is unstable!
February 5, 2019
RegMed Investors’ (RMi) closing bell: a step backward after a number of steps forward?
February 4, 2019
RegMed Investors’ (RMi) closing bell: low volume sets today’s “journey”
February 1, 2019
RegMed Investors’ (RMi) closing bell: First trading day of new month
January 31, 2019
RegMed Investors’ (RMi) closing bell: The sector surges
January 30, 2019
RegMed Investors’ (RMi) closing bell: investors need to comprehend the refracting light in the prism of share pricing
January 29, 2019
RegMed Investors’ (RMi) closing bell: many see volatility as a measure of risk
January 28, 2019
RegMed Investors’ (RMi) closing bell: retracement is more than a temporary reversal
January 24, 2019
RegMed Investors’ (RMi) closing bell: sector jumps making up for ground lost as the risk appetite dwindles or does it?
January 23, 2019
RegMed Investors’ (RMi) closing bell: oversold with a lack of volume, absent momentum and no retest of bottoms
January 22, 2019
RegMed Investors’ (RMi) closing bell: the CRISPR sell-off
January 20, 2019
RegMed Investors’ (RMi) closing bell: mutable values
January 17, 2019
RegMed Investors’ (RMi) closing bell: risky business
January 16, 2019
RegMed Investors’ (RMi) closing bell: where is the buzz?
January 15, 2019
RegMed Investors’ (RMi) closing bell: rummaging in the pre-LPS (loss-per-share) earnings time frame
January 14, 2019
RegMed Investors’ (RMi) closing bell: today, it’s about playing the trading ranges after back-to-back negative closes!
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors
© 2019 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.